Actually this type of liver cancer already has curative treatment options. I believe they used this cancer because it has no known targets for immunotherapies, so is an ideal tumour type to prove the onCARlytics concept/MOA.
Someone correct me if I'm wrong.
Ann: onCARlytics with ARTEMIS T cells show anti-tumour activity, page-49
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
-0.001(1.69%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.9¢ | 5.7¢ | $136.0K | 2.336M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 737880 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 375714 | 15 |
View Market Depth
| Last trade - 10.22am 30/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |